We are live on ! Find out more
BIOL

Biolase, Inc.
BIOL

Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

37 hedge funds and large institutions have $41.2M invested in Biolase, Inc. in 2013 Q2 according to their latest regulatory filings, with 37 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more call options, than puts

Call options by funds: $7K | Put options by funds: $3K

Holders
37
Holders Change
+37
Holders Change %
–
% of All Funds
1.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
37
Increased
–
Reduced
–
Closed
–
Calls
$7K
Puts
$3K
Net Calls
+$4K
Net Calls Change
+$4K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SNC
26
Stifel Nicolaus & Co
Missouri
$117K +$168K +3 New
AQR Capital Management
27
AQR Capital Management
Connecticut
$106K +$112K +2 New
RhumbLine Advisers
28
RhumbLine Advisers
Massachusetts
$105K +$112K +2 New
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
$87K +$112K +2 New
JP Morgan Chase
30
JP Morgan Chase
New York
$77K +$112K +2 New
BA
31
BlackRock Advisors
Delaware
$68K +$112K +2 New
Deutsche Bank
32
Deutsche Bank
Germany
$67K +$112K +2 New
T. Rowe Price Associates
33
T. Rowe Price Associates
Maryland
$61K +$55.9K +1 New
GC
34
Guggenheim Capital
Illinois
$54K +$55.9K +1 New
Principal Financial Group
35
Principal Financial Group
Iowa
$54K +$55.9K +1 New
BNP Paribas Financial Markets
36
BNP Paribas Financial Markets
France
$45.4K +$55.9K +1 New
NFA
37
Nationwide Fund Advisors
Ohio
$36K +$55.9K +1 New
U
38
UBS
Switzerland
$20K – – –
AllianceBernstein
39
AllianceBernstein
Tennessee
$16K – – –
TRCT
40
Tower Research Capital (TRC)
New York
$12K – – –
Ameriprise
41
Ameriprise
Minnesota
$7K – – –
Barclays
42
Barclays
United Kingdom
$7K – – –
Creative Planning
43
Creative Planning
Kansas
$5K – – –
Citigroup
44
Citigroup
New York
$4K – – –
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4K – – –
MAM
46
Meeder Asset Management
Ohio
$4K – – –
RFC
47
Russell Frank Company
Washington
$4K – – –
Group One Trading
48
Group One Trading
Illinois
$3K – – –
LTFS
49
Ladenburg Thalmann Financial Services
Florida
$2K – – –
1
2

BIOL Hedge Fund Activity: Q2 2013 in Review

37 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q2 2013, worth a combined $41.2M.

Buyers outnumbered sellers: 37 funds opened new BIOL positions and 0 closed out — a net gain of 37 holders — while 0 added to existing stakes and 0 trimmed.

  • 37 institutional investors held Biolase, Inc. (BIOL) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $41.2M of Biolase, Inc. stock for Q2 2013.
  • 37 funds opened new Biolase, Inc. positions in Q2 2013 and 0 closed out, a net change of +37 holders.

Based on aggregated 13F filings for Q2 2013.